Very mild senile dementia of the Alzheimer type. I. Clinical assessment

E. H. Rubin, J. C. Morris, E. A. Grant and T. Vendegna
Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110.

We report a longitudinal study of 16 subjects originally enrolled in the Washington University (St Louis, Mo) Memory and Aging Project with Clinical Dementia Rating (CDR) of "questionable" dementia (CDR 0.5). A 0.5 rating was intended to characterize subjects in whom mild cognitive impairment due to senile dementia of the Alzheimer type was suspected but was insufficient in degree to warrant a diagnosis of definite dementia. Over an 84-month follow-up period, 11 of the 16 subjects either had Alzheimer's disease verified post mortem or had clinically progressed to a more advanced CDR stage in which the dementia was clearly evident. These results suggest that the CDR 0.5 stage likely represents the incipient clinical manifestation of Alzheimer's disease and that the majority of subjects with CDR 0.5 have "very mild senile dementia of the Alzheimer type." Performance on several standard clinical scales was significantly different when comparing a larger sample of controls (n = 83), subjects with CDR 0.5 (n = 41), and subjects with mild senile dementia of the Alzheimer type (score of 1; n = 68).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mild Cognitive Dysfunction: An Epidemiological Perspective With an Emphasis on African Americans
Unverzagt et al.
J Geriatr Psychiatry Neurol 2007;20:215-226.
ABSTRACT  

Neuropsychological Markers of Progression From Mild Cognitive Impairment to Alzheimer's Disease
Marcos et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2006;21:189-196.
ABSTRACT  

Mild cognitive impairment: a cross-national comparison
Arnaiz et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:1275-1280.
ABSTRACT | FULL TEXT  

Efficacy of donepezil in mild cognitive impairment: A randomized placebo-controlled trial
Salloway et al.
Neurology 2004;63:651-657.
ABSTRACT | FULL TEXT  

Morphometry of the corpus callosum in patients with questionable and mild dementia
Hensel et al.
J. Neurol. Neurosurg. Psychiatry 2002;73:59-61.
ABSTRACT | FULL TEXT  

MRI measures of entorhinal cortex vs hippocampus in preclinical AD
Killiany et al.
Neurology 2002;58:1188-1196.
ABSTRACT | FULL TEXT  

Prevalence of cognitive impairment: Data from the Indianapolis Study of Health and Aging
Unverzagt et al.
Neurology 2001;57:1655-1662.
ABSTRACT | FULL TEXT  

Classification criteria for mild cognitive impairment: A population-based validation study
Ritchie et al.
Neurology 2001;56:37-42.
ABSTRACT | FULL TEXT  

Predicting Conversion to Alzheimer Disease Using Standardized Clinical Information
Daly et al.
Arch Neurol 2000;57:675-680.
ABSTRACT | FULL TEXT  

Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD
Schipper et al.
Neurology 2000;54:1297-1304.
ABSTRACT | FULL TEXT  

Vitamin E and Alzheimer disease: the basis for additional clinical trials1
Grundman
Am. J. Clin. Nutr. 2000;71:630s-636s.
ABSTRACT | FULL TEXT  

A Prospective Study of Cognitive Function and Onset of Dementia in Cognitively Healthy Elders
Rubin et al.
Arch Neurol 1998;55:395-401.
ABSTRACT | FULL TEXT